Rheumatology
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Hypothyroidism in vasculitis
2021
-
Impact of the COVID-19 Pandemic on Juvenile Idiopathic Arthritis Presentation and Research Recruitment: Results from the CAPRI Registry (135/140).
2021
-
Impact of the COVID-19 pandemic on juvenile idiopathic arthritis presentation and research recruitment: results from the CAPRI registry.
keab812.
2021
-
Contextualizing temporal arterial magnetic resonance angiography in the diagnosis of giant cell arteritis: a retrospective cohort study.
60:4229-4237.
2021
-
Comment on: Influence of prior antibiotic use on risk of rheumatoid arthritis: case–control study in general practice. Reply.
60:e150-e150.
2021
-
Association between age at disease onset of anti-neutrophil cytoplasmic antibody–associated vasculitis and clinical presentation and short-term outcomes.
60:617-628.
2021
-
Response to placebo in non-renal, non-neuropsychiatric systemic lupus erythematosus: a systematic review and pooled analysis.
60:73-80.
2021
-
Long-term outcomes and disease course of children with juvenile idiopathic arthritis in the ReACCh-Out cohort: a two-centre experience.
59:3727-3730.
2020
-
Corrigendum to: Incidence and prevalence of giant cell arteritis in Ontario, Canada.
59:3584-3584.
2020
-
Incidence and prevalence of giant cell arteritis in Ontario, Canada.
59:3250-3258.
2020
-
A new Canadian inception cohort for juvenile idiopathic arthritis: The Canadian Alliance of Pediatric Rheumatology Investigators Registry.
59:2796-2805.
2020
-
Influence of prior antibiotic use on risk of rheumatoid arthritis: case control study in general practice.
59:1281-1287.
2020
-
Derivation of an angiographically based classification system in Takayasu’s arteritis: an observational study from India and North America.
59:1118-1127.
2020
-
Changes in skin score in early diffuse cutaneous systemic sclerosis are associated with changes in global disease severity.
59:398-406.
2020
-
Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality.
58:636-644.
2019
-
020. IDENTIFICATION OF TARGET ANTIGENS FOR ANTI-ENDOTHELIAL CELL ANTIBODIES IN PATIENTS WITH TAKAYASU’S ARTERITIS USING PROTEOMICS.
58.
2019
-
035. CANDIDATE BIOMARKERS IN ANCA-ASSOCIATED VASCULITIS IDENTIFIED USING A PROTEOMIC APPROACH.
58.
2019
-
043. SUBGLOTTIC STENOSIS AND ENDOBRONCHIAL DISEASE IN GRANULOMATOSIS WITH POLYANGIITIS.
58.
2019
-
045. EVALUATION OF NOVEL SERUM BIOMARKERS OF DISEASE ACTIVITY IN GIANT CELL ARTERITIS, TAKAYASU’S ARTERITIS, POLYARTERITIS NODOSA, AND EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS.
58.
2019
-
083. COMPARISON OF ARTERIAL PATTERNS OF DISEASE IN TAKAYASU’S ARTERITIS AND GIANT CELL ARTERITIS.
58.
2019
-
084. DISCOVERY AND VALIDATION OF A NOVEL ANGIOGRAPHIC CLASSIFICATION SCHEME IN TAKAYASU’S ARTERITIS.
58.
2019
-
090. A CLINICAL SCORING SYSTEM FOR RISK STRATIFICATION OF GIANT CELL ARTERITIS.
58.
2019
-
138. DIFFUSE ALVEOLAR HEMORRHAGE, PULMONARY NODULES AND INFILTRATES IN GRANULOMATOSIS POLYANGIITIS AND MICROSCOPIC POLYANGIITIS. A COHORT STUDY OF 736 PATIENTS.
58.
2019
-
139. UTILIZATION OF CANADIAN HEALTHCARE ADMINISTRATIVE DATABASES TO ACCURATELY IDENTIFY CASES OF ANCA-ASSOCIATED VASCULITIS.
58.
2019
-
148. SHORT-FORM 36 AS A MEASURE OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH GIANT CELL ARTERITIS.
58.
2019
-
275. FACTORS ASSOCIATED WITH DISEASE PROGRESSION IN PATIENTS WITH MYELOPEROXIDASE-ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-RELATED PULMONARY FIBROSIS.
58.
2019
-
Renal relapse in antineutrophil cytoplasmic autoantibody-associated vasculitis: unpredictable, but predictive of renal outcome.
58:103-109.
2019
-
Treatment of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review.
57:1802-1811.
2018
-
The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts.
57:1623-1631.
2018
-
Evaluation of damage in giant cell arteritis.
57:322-328.
2018
-
Evaluating the design and reporting of pragmatic trials in osteoarthritis research.
57:59-63.
2018
-
Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort.
56:1111-1122.
2017
-
The effect of rheumatoid arthritis–associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis.
56:kew474-kew474.
2017
-
Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenues.
56:kew441-kew441.
2017
-
WS1_1 Sputum Anti-neutrophil Cytoplasmic Antibodies (ANCA) in Eosinophilic Granulamatosis and Polyangiitis (eGPA).
56:iii17-iii19.
2017
-
BSR and BHPR guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologics.
56:313-316.
2017
-
Calcinosis is associated with digital ischaemia in systemic sclerosis—a longitudinal study.
55:2148-2155.
2016
-
Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: results from the Canadian Early Arthritis Cohort.
55:1751-1762.
2016
-
Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis.
54:1351-1359.
2015
-
What drives the comparative effectiveness of biologics vs methotrexate in rheumatoid arthritis? Meta-regression and graphical inspection of suspected clinical factors.
53:1264-1273.
2014
-
Are there differences between young- and older-onset early inflammatory arthritis and do these impact outcomes? An analysis from the CATCH cohort.
53:1075-1086.
2014
-
The prevalence of vertebral fracture on vertebral fracture assessment imaging in a large cohort of patients with rheumatoid arthritis.
53:821-827.
2014
-
Unilateral vs bilateral symptomatic knee osteoarthritis: associations between pain intensity and function.
52:2229-2237.
2013
-
All-cause hospitalizations in systemic lupus erythematosus from a large Canadian referral centre.
52:905-909.
2013
-
Increased production of IL-5 and dominant Th2-type response in airways of Churg–Strauss syndrome patients.
51:1887-1893.
2012
-
von Willebrand factor antigen--a possible biomarker of disease activity in childhood central nervous system vasculitis?.
51:1838-1845.
2012
-
Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone.
51:571-576.
2012
-
Association of myocardial infarctions with COX-2 inhibition may be related to immunomodulation towards a Th1 response resulting in atheromatous plaque instability: an evidence-based interpretation.
49:837-843.
2010
-
Investigating the role of the interleukin-23/-17A axis in rheumatoid arthritis.
48:1581-1589.
2009
-
Intrinsic pathway of apoptosis in peripheral blood eosinophils of Churg–Strauss syndrome.
48:1202-1207.
2009
-
Reports of abnormal cervical cancer screening tests in systemic sclerosis.
48:149-151.
2009
-
Quality of randomized clinical trials in juvenile idiopathic arthritis.
47:640-645.
2008
-
Arthritis risk after acute bacterial gastroenteritis.
47:200-204.
2008
-
Developing a disease activity tool for systemic-onset juvenile idiopathic arthritis by international consensus using the Delphi approach.
44:1574-1578.
2005
-
What does ‘active disease’ mean? patient and parent perceptions of disease activity in the systemic arthritis form of juvenile idiopathic arthritis (SO-JIA).
44:796-799.
2005
-
Acupuncture for the alleviation of lateral epicondyle pain: a systematic review.
43:1085-1090.
2004
-
Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience.
43:992-999.
2004
-
Inaccuracy in the diagnosis of fibromyalgia syndrome: analysis of referrals.
42:263-267.
2003
-
Stevens-Johnson syndrome in association with hydroxychloroquine treatment for rheumatoid arthritis.
41:A473-474.
2002
-
Characteristics of septic arthritis in human immunodeficiency virus- infected haemophiliacs versus other risk groups.
38:139-142.
1999
-
Auranofin.
36:560-572.
1997
-
Salmon calcitonin nasal spray in the prevention of corticosteroid- induced osteoporosis.
36:255-259.
1997
-
SENSITIVITY AND SPECIFICITY OF DIFFERENT DIAGNOSTIC CRITERIA FOR BEHÇET'S DISEASE ACCORDING TO THE LATENT CLASS APPROACH.
34:932-935.
1995
-
Successful Treatment of Gold-induced Aplastic Anaemia with Granulocyte Macrophage Colony Stimulating Factor.
31:428-429.
1992
-
Prior Score Availability: Observations Using The WOMAC Osteoarthritis Index.
30:150-151.
1991
-
INTERACTION OF IBUPROFEN AND WARFARIN ON PRIMARY HAEMOSTASIS.
28:46-49.
1989
-
INCREASED INTESTINAL PERMEABILITY IN PATIENTS WITH RHEUMATOID ARTHRITIS: A SIDE-EFFECT OF ORAL NONSTEROIDAL ANTI-INFLAMMATORY DRUG THERAPY?.
26:103-107.
1987
-
PUNCHED-CARD AID IN RHEUMATOLOGICAL DIAGNOSIS.
26:46-50.
1987
-
Reinforcement of Bias in the Medical Literature: Nonsteroidal Anti-inflammatory Drugs and the Stomach—a Case in Poin.
26:231-232.
1987
-
Causal pathways to health-related quality of life in children with juvenile idiopathic arthritis: results from the ReACCh-Out cohort
2021
-
Subglottic stenosis and endobronchial disease in granulomatosis with polyangiitis
2019
-
A CLINICAL SCORING SYSTEM FOR RISK STRATIFICATION OF GIANT CELL ARTERITIS
2019
-
CLUSTER ANALYSIS TO EXPLORE CLINICAL SUBCLASSIFICATION OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG-STRAUSS)
2019
-
DIFFUSE ALVEOLAR HEMORRHAGE, PULMONARY NODULES AND INFILTRATES IN GRANULOMATOSIS POLYANGIITIS AND MICROSCOPIC POLYANGIITIS. A COHORT STUDY OF 736 PATIENTS
2019
-
FACTORS ASSOCIATED WITH DISEASE PROGRESSION IN PATIENTS WITH MYELOPEROXIDASE-ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-RELATED PULMONARY FIBROSIS
2019
-
GENETIC EVIDENCE OF EOSINOPHIL NUMBER UNDERPINNING PR3-AAV AND PLAUSIBLE HOST GENETIC PREDISPOSITION TO MICROBIAL DRIVERS OF DISEASE
2019
-
THE EFFECT OF PLASMA EXCHANGE ON END-STAGE RENAL DISEASE AND DEATH IN PATIENTS WITH SEVERE ANCA-ASSOCIATED VASCULITIS
2019
-
THE EFFECT OF REDUCED-DOSE ORAL GLUCOCORTICOIDS DURING INDUCTION OF REMISSION INDUCTION IN SEVERE ANCA-ASSOCIATED VASCULITIS
2019
-
UTILIZATION OF CANADIAN HEALTHCARE ADMINISTRATIVE DATABASES TO ACCURATELY IDENTIFY CASES OF ANCA-ASSOCIATED VASCULITIS
2019
-
VERITAS: VASCULITIS: EFFECTS OF REMISSION MAINTENANCE THERAPIES ON RELAPSE AND SIDE EFFECTS ON PATIENT PREFERENCES: A STUDY PROTOCOL
2019
-
A RANDOMIZED DOUBLE-BLIND TRIAL OF ABATACEPT AND GLUCOCORTICOIDS FOR THE TREATMENT OF TAKAYASU'S ARTERITIS
2017
-
ARTERIAL LESIONS IN GIANT CELL ARTERITIS
2017
-
DEMOGRAPHIC CHARACTERISTICS OF JAPANESE PARTICIPANTS IN PEXIVAS AS COMPARED WITH REMIT-JAV
2017
-
DISCREPANCIES BETWEEN CLINICAL- AND IMAGING-BASED ASSESSMENTS OF DISEASE ACTIVITY IN TAKAYASU'S ARTERITIS
2017
-
IDENTIFICATION OF FUNCTIONAL AND EXPRESSION POLYMORPHISMS ASSOCIATED WITH RISK FOR ANTI-NEUTROPHIL CYTOPLASMIC AUTOANTIBODY-ASSOCIATED VASCULITIS
2017
-
LATE-ONSET RELAPSE IN PATIENTS WITH SYSTEMIC VASCULITIS
2017
-
PATIENT REPORTED OUTCOMES AS PREDICTORS OF FLARES IN TAKAYASU ARTERITIS
2017
-
PLASMA EXCHANGE AND GLUCOCORTICOID DOSING IN THE TREATMENT OF ANTI-NEUTROPHIL CYTOPLASM ANTIBODY ASSOCIATED VASCULITIS: BASELINE CHARACTERISTICS OF A RANDOMIZED CONTROLLED TRIAL (PEXIVAS)
2017
-
PREVALENCE OF IMMUNOFLUORESCENT DEPOSITS IN ANCA ASSOCIATED VASCULITIS
2017
-
SPUTUM ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) IN EOSINOPHILIC GRANULAMATOSIS AND POLYANGIITIS (EGPA)
2017
-
THE STEROID TAPERING IN ANCA VASCULITIS EVALUATION STUDY (STAVE) 2: A SYSTEMATIC REVIEW AND META-ANALYSIS
2017
-
TWO INTERNATIONAL MULTIREGIONAL INVESTIGATOR INITIATED CLINICAL TRIALS ON VASCULITIS: COLLABORATION WITH EUVAS, VCRC AND NATIONWIDE VASCULITIS STUDY GROUPS OF JAPAN
2017
-
URINARY EPIDERMAL GROWTH FACTOR AS A BIOMARKER OF RENAL INVOLVEMENT IN ANCA-ASSOCIATED VASCULITIS
2017
-
UTILITY OF MEASUREMENTS OF URINARY SOLUBLE CD163 & MCP1 IN THE IDENTIFICATION OF SUBTLE RENAL FLARES IN ANCA VASCULITIS
2017
-
Gout in paleopathology; The elusive nature of urate
2007
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)